Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Kintsugi Voice Device Pivotal Study

NCT: NCT06809907 · COMPLETED

NCT IDNCT06809907
StatusCOMPLETED
Start Date2025-03-27
Completion2026-02-28
SponsorKintsugi Mindful Wellness, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

A prospective, single arm, non-randomized, pivotal clinical validation study to evaluate the ability of the Kintsugi Voice Device (the Device) to aid clinical assessment for depression by comparing its output with a diagnosis made by a clinician using the Structured Clinical Interview for DSM-5 (SCID-5-RV) for up to 1000 English speaking adult patients ages 22 and older living in the United States. Recruitment will occur for 1 year and participation will be for up to 2 weeks

Frequently Asked Questions

What is Kintsugi Voice Device Pivotal Study?

Kintsugi Voice Device Pivotal Study is a clinical trial registered under NCT06809907. Current status: COMPLETED.

What is the status of NCT06809907?

The current status of NCT06809907 (Kintsugi Voice Device Pivotal Study) is: COMPLETED.

When did Kintsugi Voice Device Pivotal Study start?

Kintsugi Voice Device Pivotal Study started on 2025-03-27.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.